These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31369723)

  • 21. Factors associated with serum HCV RNA positivity in anti-HCV antibody positive intravenous drug users.
    Pirisi M; Toniutto P; Fabris C; Lombardelli T; Falleti E; Tisminetzky SG; Baralle F; Bartoli E
    J Clin Epidemiol; 1998 May; 51(5):423-7. PubMed ID: 9619970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
    Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
    Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
    J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Seroprevalence Study of Hepatitis B and C Virus Infections in a Hospitalized Population in Romania, an Opportunity for a Better National Prevention and Control Strategy.
    Popovici O; Molnar GB; Popovici F; Janţă D; Pistol A; Azoicăi D
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):25-32. PubMed ID: 27014751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
    Wolffram I; Petroff D; Bätz O; Jedrysiak K; Kramer J; Tenckhoff H; Berg T; Wiegand J;
    J Hepatol; 2015 Jun; 62(6):1256-64. PubMed ID: 25617500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
    Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
    Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
    Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
    J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients.
    Lobstein S; Kaiser T; Liebert U; Wojan M; Leichtle A; Mössner J; Wiegand J; Tillmann HL
    Z Gastroenterol; 2008 May; 46(5):415-20. PubMed ID: 18461515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of a hepatitis C screening tool in primary care.
    McGinn T; O'Connor-Moore N; Alfandre D; Gardenier D; Wisnivesky J
    Arch Intern Med; 2008 Oct; 168(18):2009-13. PubMed ID: 18852403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
    Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
    Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of HCV infection in the general population: a survey in a southern Italian town.
    Cozzolongo R; Osella AR; Elba S; Petruzzi J; Buongiorno G; Giannuzzi V; Leone G; Bonfiglio C; Lanzilotta E; Manghisi OG; Leandro G; ; Donnaloia R; Fanelli V; Mirizzi F; Parziale L; Crupi G; Detomaso P; Labbate A; Zizzari S; Depalma M; Polignano A; Lopinto D; Daprile G
    Am J Gastroenterol; 2009 Nov; 104(11):2740-6. PubMed ID: 19638964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Earlier Detection of Hepatitis C Virus Infection Through Routine Hepatitis C Virus Antibody Screening of Human Immunodeficiency Virus-Positive Men Who Have Sex With Men Attending A Sexually Transmitted Infection Outpatient Clinic: A Longitudinal Study.
    van Rooijen M; Heijman T; de Vrieze N; Urbanus A; Speksnijder A; van Leeuwen P; de Vries H; Prins M
    Sex Transm Dis; 2016 Sep; 43(9):560-5. PubMed ID: 27513382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C Virus Reflex Testing Protocol in an Emergency Department.
    Manteuffel JJ; Lee MS; Bussa RM; Sabagha NL; Chaudhry K; Ross JE; Cook MR; Rammal JK; Sridasyam K; Klausner HA; Samuel LP; Miller JB
    West J Emerg Med; 2022 Feb; 23(2):108-114. PubMed ID: 35302440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus testing for case identification in persons born during 1945-1965: Results from three randomized controlled trials.
    Yartel AK; Rein DB; Brown KA; Krauskopf K; Massoud OI; Jordan C; Kil N; Federman AD; Nerenz DR; Brady JE; Kruger DL; Smith BD
    Hepatology; 2018 Feb; 67(2):524-533. PubMed ID: 28941361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.
    Carey KJ; Huang W; Linas BP; Tsui JI
    J Subst Abuse Treat; 2016 Jul; 66():54-9. PubMed ID: 26988423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
    Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
    Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.
    Hossain N; Puchakayala B; Kanwar P; Verma S; Abraham G; Ivanov Z; Niaz MO; Mohanty SR
    Dig Dis Sci; 2017 Nov; 62(11):3193-3199. PubMed ID: 28913613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based study.
    Bielen R; Koc ÖM; Busschots D; Robaeys G; Aertgeerts B; Vaes B; Mamouris P; Mathei C; Goderis G; Nevens F
    BMJ Open; 2019 May; 9(5):e026464. PubMed ID: 31072855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system.
    Geboy AG; Nichols WL; Fernandez SJ; Desale S; Basch P; Fishbein DA
    PLoS One; 2019; 14(5):e0216459. PubMed ID: 31120906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.